ICER to payers: Go easy on CGRP restrictions if pricing stays reasonable
admin 5th July 2018 Uncategorised 0The Institute for Clinical and Economic Review isn’t taking a new group of migraine drugmakers to task over high costs. But it does have some suggestions for payers about how to manage the drugs.
More: ICER to payers: Go easy on CGRP restrictions if pricing stays reasonable
Source: fierce